A Polytomous Rasch Analysis of the English Version of Health-Related Quality of Life for Drug Abusers Test

  1. Lozano Rojas, Óscar Martín
  2. Rojas Tejada, Antonio José
  3. Foresti, Katia
  4. Zubaran, Carlos
Revista:
The Spanish Journal of Psychology

ISSN: 1138-7416

Ano de publicación: 2015

Volume: 18

Tipo: Artigo

DOI: 10.1017/SJP.2015.34 DIALNET GOOGLE SCHOLAR lock_openAcceso aberto editor

Outras publicacións en: The Spanish Journal of Psychology

Obxectivos de Desenvolvemento Sustentable

Resumo

The specific aim of this study was to analyze the psychometric properties of the English version of the Health-Related Quality of Life for Drug Abusers Test (HRQoLDA Test) applying the Rasch model, and emphasizing fit between empirical data and theoretical Rasch model assumptions; item(s) category probability curve; and precision in terms of information function. In this study, the authors present the results of the translation and adaptation of the original Spanish version to English, as applied to a sample of substance users in Australia. The authors evaluated 121 adults recruited from inpatient and outpatient treatment facilities in Sydney, Australia. The Rating Scale Model was used in the psychometric analysis of the English version of the HRQoLDA Test. The items and persons revealed a fit between the reported data and the model. It was also demonstrated that respondents did not discriminate among the five response categories, which led to a reduction to three response categories. The adaptation of the TECVASP to the English language, renamed the HRQoLDA test, as developed with an Australian sample revealed adequate psychometric properties.

Referencias bibliográficas

  • American Psychiatric Association. (1994). The diagnostic and statistical manual of mental disorders, (4th Ed). Washington DC: American Psychiatric Association.
  • Brogly S., Mercier C., Bruneau J., Palepu A., & Franco E. (2003). Towards more effective public health programming for injection drug users: Development and evaluation of the Injection Drug User Quality of Life Scale. Substance Use & Misuse, 38, 965–992. http://dx.doi.org/10.1081/JA-120017619
  • Chachamovich E., Fleck M. P., & Power M. (2009). Literacy affected ability to adequately discriminate among categories in multipoint Likert Scales. Journal of Clinical Epidemiology, 62, 37–46. http://dx.doi.org/10.1016/j.jclinepi.2008.03.002
  • Conrad K. J., & Smith E. V. Jr. (2004). International conference on objective measurement: Applications of Rasch analysis in health care. Medical Care, 42, 1–6. http://dx.doi.org/10.1097/01.mlr.0000103527.52821.1c
  • Domingo-Salvany A., Brugal M. T., Barrio G., GonzálezSaiz F., Bravo M. J., de la Fuente L., & the ITINERE Investigators (2010). Gender differences in health related quality of life of young heroin users. Health Qual Life Outcomes, 8, 145. http://dx.doi.org/10.1186/1477-7525-8-145
  • Edwards G., & Gross M. M. (1976). Alcohol dependence: Provisional description of a clinical syndrome. British Medical Journal, 1, 1058–1061. http://dx.doi.org/10.1136/ bmj.1.6017.1058
  • Globe D. R. (1999). Associations of clinical parameter with health-related quality of life in hospitalized persons with HIV disease. AIDS Care, 11, 71–86. http://dx.doi.org/10.1080/09540129948216
  • González-Saiz F., Lozano Rojas O. M., Martín Esteban J., Bilbao Acedos I., Ballesta Gómes R., & Gutiérrez-Ortega J. (2011). Comorbilidad psiqiuátrica en una muestra de pacientes con dependencia de opiáceos tratados con buprenorfina sublingual en régimen de comunidad terapéutica [Psychiatric comorbidity in a sample of opiate-dependent patients treated with sublingual buprenorphine in a therapeutic community regime]. Revista de Psiquiatría y Salud Mental, 4, 81–87. http://dx.doi.org/10.1016/S2173-5050(11)70013-9
  • Hays R. D., Morales L. S., & Reise S. P. (2000). Item response theory and health outcomes measurement in the 21st century. Medical Care, 38(9 Suppl): II28–II42. http://dx.doi.org/10.1097/00005650-200009002-00007
  • Hunt S. M., McEwen J., & McKenna S. P. (1985). Measuring health status: A new tool for clinicians and epidemiologists. The Journal of the Royal College of General Practitioners, 35, 185–188.
  • Iraurgi I. (1999). Estimación de la calidad de vida en toxicomanías mediante el cuestionario MOS-SF-35: Estructura factorial, consistencia interna y validez. [Estimating the quality of life in addiction by MOS-SF-35 survey: Factor structure, internal consistency and validity]. Revista Española de Drogodependencias, 24, 31–45.
  • Iraurgi I. (2008). Escala de Calidad de Vida en Usuarios de Drogas Inyectadas (IDUQoL): Valoración psicométrica de la versión española [Injection Drug User Quality of Life Scale (IDUQoL), psychometric assessment of the Spanish version]. Adicciones, 20, 281–294.
  • Linacre J. M. (2000). Winsteps® [Computer Software]. Beaverton, Oregon: Winsteps.com.
  • Linacre J. M. (2014). Winsteps® Rasch measurement computer program User's Guide. Beaverton, Oregon: Winsteps.com.
  • Lozano O. M., Domingo-Salvany A., Martínez-Alonso M., Brugal M. T., Alonso J., de la Fuente L., & the ITINERE Investigators (2008). Health-related quality of life in young cocaine users and associated factors. Quality of Life Research, 17, 977–985. http://dx.doi.org/10.1007/s11136-008-9376-8
  • Lozano O. M., Rojas A. J., & Pérez C. (2005). Construcción de un test para medir la calidad de vida relacionada con la salud específico para drogodependientes [Developing a test to assess health-related quality of life in drugg addicts]. Sevilla, Spain: Consejería para la Igualdad y Bienestar Social. Junta de Andalucía.
  • Lozano O. M., Rojas A. J., Pérez C., González-Saiz F., Ballesta R., & Bilbao I. (2008). Evidencias de validez del Test para la Evaluación de la Calidad de Vida en Adictos a Sustancias Psicoactivas (TECVASP) a partir del Modelo Bi-Axial de la adicción [Validity evidence of the Health Related Quality of Life for Drug Abusers Test based on the Biaxial Model of Addiction]. Psicothema, 20, 317–323.
  • Lozano Rojas O. M., Rojas Tejada A. J., & Pérez Meléndez C. (2009). Development of a specific health-related quality of life test in drug abusers using the Rasch rating scale model. European Addiction Research, 15, 63–70. http://dx.doi.org/10.1159/000189784
  • Lozano Rojas O. M., Rojas Tejada A. J., Pérez Meléndez C., Apraiz Granados B., Sánchez Muñoz F., & Marín Bedoya A. (2007). Test para la Evaluación de la Calidad de Vida en Adictos a Sustancias Psicoactivas (TECVASP): Estudios de fiabilidad y validez [Assessment of the Quality of Life in Psychoactive Substance Addicts Test: Reliability and validity studies]. Trastornos Adictivos, 9, 97–107. http://dx.doi.org/10.1016/S1575-0973(07)75635-0
  • MCHorney C. A., Haley S. M., & Ware J. E. (1997). Evaluation of the MOS SF-36 Physical Functioning Scale (PF-10): II. Comparison of relative precision using Likert and Rasch scoring methods. Journal of Clinical Epidemiology, 50, 451–461.
  • Mokkink L. B., Terwee,. C. B., Patrick D. L., Alonso J., Stratford P. W., Knol D. L., … de Vet H. C. W., (2012). COSMIN checklist manual. Amsterdam, The Netherlands: Institute for Health and Care Research.
  • Morales-Manrique C. C., Valderrama-Zurian J. C., Castellano-Gómez M., Aleixandre-Benavent R., Palepu A., & Cocaine Group C. V. (2007). Cross cultural adaptation of the Injection Drug User Quality of Life Scale (IDUQOL) in Spanish drug dependent population, with or without injectable consumption: Drug USer Quality of Life Scale-Spanish (DUQOL-Spanish). Addictive Behaviors, 32, 1913–1921. http://dx.doi.org/10.1016/j.addbeh.2006.12.006
  • Muñiz J., Elosua P., & Hambleton R. K. (2013).Directrices para la traducción y adaptación de los tests: Segunda edición [International Test Commission Guidelines for test translation and adaptation: Second edition]. Psicothema, 25, 151–157. http://dx.doi.org/10.7334/psicothema2013.24
  • Pallant J. F., & Tennant A. (2007). An introduction to the Rasch measurement model: An example using the Hospital Anxiety and Depression Scale (HADS). British Journal of Clinical Psychology, 46, 1–18. http://dx.doi.org/10.1348/014466506X96931
  • Raisch D. W., Campbell H. M., Garnand D. A., Jones M. A., Sather M. R., Naik R., & Ling W. (2012). Health-related quality of life changes associated with buprenorphine treatment for opioid dependence. Quality of Life Research, 21, 1177–1183. http://dx.doi.org/10.1007/s11136-011-0027-0
  • Reise S. P., & Henson J. M. (2003). A discussion of modern versus traditional psychometrics as applied to personality assessment scales. Journal of Personality Assessment, 81, 93–103. http://dx.doi.org/10.1207/S15327752JPA8102_01
  • Reno R. R., & Aiken L. S. (1993). Life activities and life quality of heroin addicts in and out of methadone treatment. Substance Use & Misuse, 28, 211–232. http://dx.doi.org/10.3109/10826089309039624
  • Revici D. A., Chen W., & Gelhorn H. (2013). Rasch model analyses and small sample size. Evidence Matters, 19–22.
  • Scientific Advisory Committee of the Medical Outcomes Trust (2002). Assessing health status and quality-of-life instruments: attributes and review criteria. Quality Life Reseach, 11, 193–205.
  • Smith A. B., Rush R., Fallowfield L. J., Velikova G., & Sharpe M. (2008). Rasch fit statistics and sample size considerations for polytomous data. BMC Medical Research Methodology, 8, 33. http://dx.doi.org/10.1186/1471-2288-8-33
  • Smith K. W., & Larson M. J. (2003). Quality of life assessments by adult substance abusers receiving publicly funded treatment in Massachusetts. American Journal of Drug and Alcohol Abuse, 29, 323–335. http://dx.doi.org/10.1081/ADA-120020517
  • Smith R. (2000). Fit analysis in latent trait measurement models. Journal of Applied Measurement, 1, 199–218.
  • The WHOQOL Group (1994). The development of the World Health Organization Quality of Life Assessment Instrument. In J. Orley & W. Kuyken (Ed.), Quality of Life Assessment: International perspectives (pp. 41–60). Heidelberg, Alemania: Springer-Verlag.
  • Tiffany S. T., Friedman L., Greenfield S. F., Hasin D. S., & Jackson R. (2012). Beyond drug use: A systematic consideration of other outcomes in evaluations of treatments for substance use disorders. Addiction, 107, 709–718. http://dx.doi.org/10.1111/j.1360-0443.2011.03581.x
  • Wan C., Fang J., Jiang R. Shen J., Jiang D., Tu X., ... Wan T. (2011). Development and validation of a quality of life instrument for patients with drug dependence: Comparisons with SF-36 and WHOQOL-100. International Journal of Nursing Studies, 48, 1080–1095. http://dx.doi.org/10.1016/j.ijnurstu.2011.02.012
  • Wang P. W., Wu H. C., Yen C. N., Yeh Y. C., Chung K. S., Chang H. C., & Yen C. F. (2012). Change in quality of life and its predictors in heroin users receiving methadone maintenance treatment in Taiwan: An 18-month follow-up study. The American Journal of Drug and Alcohol Abuse, 38, 213–219. http://dx.doi.org/10.3109/00952990.2011.649222
  • Ware J. (1997). SF-36 physical & mental health summary scales: A user’s manual. Boston, MA: Quality Metric.
  • Ware J. Jr., Kosinski M., & Keller S. D. (1996). A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34, 220–233. http://dx.doi.org/10.1097/00005650199603000-00003
  • Wright B., & Masters G. (1982). Rating scale analysis. Chicago, IL: Mesa Press; 1982.
  • Zubaran C., Sud R., Emerson J., Zolfaghari E., Foresti K., & Lozano O. (2012). Validation of the English version of the Health-Related Quality of Life for Drug Abusers (HRQoLDA) test. European Addiction Research, 18, 220–227. http://dx.doi.org/10.1159/000337213
Fonte de datos: Dialnet